Amid Hydroxychloroquine Uproar, Real Studies of Drug Are Suffering (New York Times, quotes Christine Johnston)

President Trump’s enthusiastic embrace of a malaria drug that he now says he takes daily — and the resulting uproar in the news media — appears to be interfering with legitimate scientific research into whether the medicine might work to prevent coronavirus infection or treat the disease in its early stages.

DGH Announces 2020 Outstanding Staff Award Recipient

The Department of Global Health recently awarded its 2020 Outstanding Staff Award to Noura Youssoufa (Academic Advisor, MPH and Undergraduate Programs). Her role as Academic Advisor includes working with prospective MPH students – both in-person, online, and at conference recruitment events – as well as organizing Visit Days for all admitted graduate students in the department.

Does Antimalarial Drug Prevent COVID-19? New DGH Study Seeks Answers (Ruanne Barnabas, ICRC)

The benefits of hydroxychloroquine being investigated in multi-site clinical trial launching in April

Researchers are investigating whether hydroxychloroquine – a commonly used anti-malarial and autoimmune drug – can prevent COVID-19.

A multi-site clinical trial, led by the University of Washington Department of Global Health/International Clinical Research Center (ICRC)  in collaboration with NYU Grossman School of Medicine, aims to definitively determine whether hydroxychloroquine can prevent transmission in people exposed to the virus.

UW study to shed light on effective strategies for cervical cancer elimination, address health disparities

A new UW study led by Ruanne Barnabas, Associate Professor, UW Department of Global Health/ International Clinical Research Center (ICRC), aims to shed light on effective strategies for cervical cancer elimination. The study will increase understanding of how a combination of screening and vaccination strategies can be used more effectively to eliminate cervical cancer in low- and middle-income countries (LMICs).

ICRC Fellow Treating Mind and Body - Jennifer Velloza, UW Magnuson Scholar.

Jennifer Velloza spent a year crisscrossing the grass-covered plains and sloping hills of rural Swaziland, dividing her time among ten medical clinics in this small southern African country. Here, nearly one in four people have HIV — and that rate is even higher among women.

As a study manager for Doctors Without Borders, Velloza saw many pregnant and postpartum women struggle to get the HIV testing and treatment they needed, because they were also suffering from sexual trauma, depression or anxiety.

UW Students, Faculty Break Barriers and Build Bridges at the AIDS 2018 Conference

More than 30 UW researchers participated in the 22nd International AIDS Conference (AIDS 2018) — the world’s largest global gathering on HIV and AIDS — to share ground-breaking science aimed at helping to address the most pressing challenges in HIV/AIDS. The conference offered an important opportunity to strengthen policies and programs around the world that ensure an evidence-based response to the epidemic.